 Propranolol prevention recurrent severe portal hypertensive gastropathy cirrhosis main causes gastrointestinal bleeding cirrhosis oesophageal varices portal hypertensive gastropathy PHG varices beta-blockers clear drugs PHG cirrhotic patients acute chronic bleeding severe PHG part randomised trial efficacy propranolol prevention PHG patients propranolol dose heart rate bpm mg mean follow-up SD months untreated controls followed-up examinations months actuarial percentages patients free PHG propranolol-treated patients untreated controls months vs months follow-up vs Propranolol-treated patients episodes acute bleeding controls vs patient month Multivariate analysis absence propranolol treatment predictive variable Actuarial survival propranolol group controls difference significant long-term propranolol treatment frequency severe PHG prognosis cirrhotic patients disorder